维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Shalansky"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Risk markers for thromboeytopenia in critically ill pa- tients : a prospective analysis 显示文摘	SHALANSKY S J VERMA A K LEVINE M	2002	Pharmacotherapy2002，22，：	1
2	Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process显示文摘	Shalansky S J Virk R Ackman M	2003	Can J Cardiol2003，19，2：	1
3	Risk markers for thrombocytopenia in critically ill patients:a prospective analysis显示文摘	Shalansky SJ Verma AK Levine M	2002	Pharmacothweapy2002，22，7：	1
4	Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process 显示文摘	Shalansky SJ Virk R Ackman M	2003	Can J Cardiol2003，19，2：	1
5	Risk markers for thrombocytopenia in critically ill patients: a prospective a- nalysis显示文摘	Shalansky SJ Verma AK Levine M	2002	Pharmaeotherapy2002，22，7：	1
6	Self-reported Morisky score for identifying nonadherenee with cardiovascular medica- tions 显示文摘	Shalansky SJ Levy AR Ignaszewski AP	2004	Ann Pharmaeother2004，38，9：	1
7	Nonchemotherapy drug-induced agranulocytosis:a review of 118 patients treated with colony-stimulating factors显示文摘	Beauchesne MF Shalansky SJ	1999	Pharmacotherapy1999，19，3：	1
8	Risk markers for thrombocytopenia in critically ill patients:a prospective analysis显示文摘	Shalansky Arun K	2002	Pharmacotherapy2002，22，7：	1
9	Risk markers for thrombocytopenia in critically ill patients:a prospective analysis显示文摘	Stephan J Shalansky Arun K	2002	Pharmacotherapy2002，22，：	1
10	Efficacy of intradialytic parenteral nutrition in malnourished hemodialysis patients显示文摘	Cherry N Shalansky K	2002	Am J Health Syst Pharm2002，59，18：	1
11	Efficacy of low -dose alteplase for treatment of hemodialysis catheter occlusions 显示文摘	HAMOND J SHALANSKY K JASTRZEBSKI J	2005	J Vasc Access2005，6，2：	1
12	Risk markers fou thrombocytopenia in criticallyillpatients: aprospecti veanalysis 显示文摘	Stephen J Shalansky Arunk	2002	Phermacotherapy2002，22，7：	1
13	Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process 显示文摘	Shalansky SJ Virk R Ackman M	2003	Can J Cardiol2003，19，2：	1
14	Acute kidney injury with Tobramycin-Impregnated bone cement spacers in prosthetic joint infections显示文摘	Aeng ES Shalansky KF Lau Tr	2015	Ann Pharmacother2015，49，11：	1
15	Risk markefS for thrombo cyto pe- nia in critically iii pat ients: a pr o spect ive analysis 显示文摘	Stephan J Shalansky Ar un K	2002	Pharmaco therapy2002，22，：	1
16	Self-Reported Morisky Score for Identifying Nonadherence with Cardio- vascular Medications显示文摘	Shalansky S J Levy A R Ignaszewski A P	2004	Ann Pharmacother2004，38，9：	1
17	Risk markers for thrombocytopenia in critically ill patients:a prospective analysis显示文摘	Shalansky S J Verma A K Levine M	2002	Pharmacotherapy2002，22，7：	1
18	N-acetylcysteine reduces urinary albumin excretion following contrast administration:evidence of biological effect 显示文摘	Levin A Pate GE Shalansky S et a	2007	Nephrol Dial Transplant2007，22，9：	1
19	Risk markerS for thrombocytopenia in critically iii patients: a prospective analysis显示文摘	Stephan J Shalansky Arun K	2002	Pharmacotherapy2002，22，：	1
20	Nonchemotherapy drug-induced agranulocytosis: A review of 118patients treated with colony-stimulating factors 显示文摘	Beauchasne Maric-Francr Shalansky Stephen L	1999	Pharmacotherapy1999，19，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示